Par Pharmaceutical Inc. is recalling 9,936 cartons of Frovatriptan Succinate Tablets (2.5mg), a prescription medication used to treat migraine headaches. The product is incorrectly labeled with an expiration date of August 2022, when the actual expiration date is April 2022. Using the medication after its true expiration date could mean the drug is less effective than intended.
The incorrect labeling may lead consumers to use the medication four months past its actual expiration date. Over time, the potency or stability of the drug may decrease, potentially resulting in inadequate treatment of migraine symptoms.
Healthcare provider consultation and pharmacy refund.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.